Home Compare GMED vs NVDA
Stock Comparison · Single-driver result

Globus Medical vs NVIDIA: Which Stock Looks Stronger in 2026?

The structural profiles are close, with NVIDIA carrying a narrow edge on profitability. Globus Medical still leads on growth and valuation, which keeps the comparison from looking entirely one-sided. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison is mainly decided in profitability, with the rest of the profile carrying less weight.

Trajectory Similarity
0.63
Moderately similar
Peer-set rank: #3
within Globus Medical, Inc.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

Most of the shared profile comes through investment intensity and revenue stability.

Similarity drivers
investment intensityrevenue stability
What reduces the match
revenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
GMED
Globus Medical, Inc.
69
Peer-Score
Signal qualityHigh
vs
NVDA
NVIDIA Corporation
73
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in profitability.

Dimension spread: GMED vs NVDA Profitability 56 98 Stability 44 53 Valuation 81 64 Growth 95 71 GMED NVDA
Gap Ranking
#1 Profitability +42
#2 Growth +24
#3 Valuation +17
#4 Stability +9
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for GMED and NVDA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer GMEDNVDA Relative valuation Structural strength

NVIDIA Corporation occupies the cheaper side of the setup map, although Globus Medical, Inc. still holds the stronger structural profile.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Both rank well on profitability, but NVIDIA Corporation still holds a clear edge.
Growth
On growth, the edge still sits with Globus Medical, Inc., even though both profiles look solid.
Profitability — Dominant Gap
GMED
56
NVDA
98
Gap+42in favour of NVDA

The profitability lead is mainly driven by a 41-point operating margin advantage.

What keeps the gap from being one-sided

Earnings growth also leans the other way, which keeps the score lead from reading as a full growth sweep.

What this means for the comparison

The main read on profitability is clearer than the broader score gap.

Explore full peer positioning in AssetNext

Break down the GMED vs NVDA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how GMED and NVDA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.